Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy-Reference-Cited by-同舟云学术

Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy

Published:2017-10-10 Issue:3 Volume:124 Page:459-465
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Donaldson Alana R.¹,McCarthy Caitlin²,Goraya Shazia²,Pederson Holly J.²,Sturgis Charles D.¹^ORCID,Grobmyer Stephen R.²^ORCID,Calhoun Benjamin C.¹^ORCID

Affiliation:

1. Department of Pathology; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic; Cleveland Ohio

2. Division of Breast Services-Department of General Surgery; Digestive Disease and Surgery Institute, Cleveland Clinic; Cleveland Ohio

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. Risk factors for breast cancer in women with proliferative breast disease;Dupont;N Engl J Med,1985

2. A prospective study of benign breast disease and the risk of breast cancer;London;JAMA,1992

3. Benign breast disease and the risk of breast cancer;Hartmann;N Engl J Med,2005

4. Atypical hyperplastic lesions of the female breast. A long-term follow-up study;Page;Cancer,1985

5. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study;Page;Lancet,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis;The Breast;2024-12

2. Precision therapy for cancer prevention by targeting carcinogenesis;Molecular Carcinogenesis;2024-08-14

3. Atypical lobular hyperplasia: what we need to know;Journal of Medical Imaging and Interventional Radiology;2024-06-12

4. Understanding Benign Breast Disease and Subsequent Breast Cancer in Hispanic White Females: A Step Closer to Evidence-Based Management;Cancer Epidemiology, Biomarkers & Prevention;2024-06-05

5. Following the High-Risk Patient: Breast Cancer Risk-Based Screening;Annals of Surgical Oncology;2024-02-01